Show results for
Refine by
Testing Services Targeting To Preclinical Studies Services In Germany
17 services found
Manufactured by:Sartorius AG based inGoettingen, GERMANY
One size doesn’t fit all – let's find a solution that fits your needs. With our longstanding albumin heritage, we can utilize our knowledge and expertise to produce a recombinant albumin as unique as your product and application demand. From bespoke formulations to alternative presentations, our dedicated recombinant human albumin GMP manufacturing facilities can meet your needs. ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Rodent disease models are widely used for a broad range of project objectives, which involve investigation of pathological process and mechanism of disease, pre-clinical tests of potential therapeutic agents, ...
by:Metecon GmbH based inMannheim, GERMANY
Getting there quickly with the right test strategy; Verification proves that your product was developed and built correctly and is thus an essential part of the development of each medical device. Based on your product specification, we develop the optimum test strategy by means of which we achieve full test coverage as well as a proper traceability matrix for tracing the specifications and ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Prior to clinical trials, it is necessary to conduct animal toxicity studies to best characterize the potential toxicity of new drug candidates. Generally, the objective of preclinical safety evaluation is to determine the toxic effects with respect to target organs, dose dependency, the relationship between clinical findings and exposure to the compound, and potential reversibility of findings. ...
Manufactured by:Sartorius AG based inGoettingen, GERMANY
A more seamless transition into the clinic. Complex biopharmaceuticals and advanced therapies can present challenges during preclinical development. When implementing an albumin-based solution, Albumedix can help avoid unnecessary complications in your preclinical testing by creating species-specific recombinant albumins to suit your preclinical models. Using our proprietary recombinant ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Pharmacokinetics (PK) dedicated to determining the mechanisms of a drug's absorption, biodistribution, when it eliminated from the body and what it becomes. It is a study of how an organism affects a drug. In vivo PK studies are critical to ensure drug candidates have appropriate PK properties that can be evaluated in preclinical pharmacology and safety studies. In vivo PK studies provide ...
Manufactured by:Genekam Biotechnology AG based inDuisburg, GERMANY
Genekam Biotechnology AG has developed a number of solutions and molecules, which can be used to inhibit the Ebola infections in order to create new therapies. These molecules can be sourced from us and laboratories around the world can conduct the research studies e.g. preclinical and clinical to demostrate that these molecules can inhibit the Ebola viruses. Not only this, we are trying to ...
by:Genome Biologics based inFrankfurt am Main, GERMANY
Loss of cardiomyocytes (heart cells) is the primary hallmark of heart failure. However, unlike other cell types, there is a limited capacity for cardiomyocytes proliferation in the adult heart and in the failing human heart. Therefore, regenerative approaches to replenish the lost cardiomyocytes are necessary to recover the contractile capacity of the heart and prevent death. Targeting ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Drug discovery and development is an attractive strategy for treating various human diseases. In particular, different types of drugs, such as vaccines, antibodies, have been generated and tested in many preclinical and clinical trials. ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
DMD is a progressive muscle wasting disease that affects approximately 1 in 3500 male births. It is caused by mutations in a large 79-exon gene encoding the dystrophin protein. The majority of mutations identified in DMD are frameshift mutations that result in complete loss of dystrophin. Patients typically present at 2-5 years of age with a waddling gait, calf hypertrophy, and difficulties in ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Animal models have been making remarkable contributions to the understanding of genetics and immune-mediated pathophysiology of allergic rhinitis. Non-human primates (NHPs) exhibit plenty of similarities with humans in terms of physiology, anatomy, neurology and many other aspects. In particular, NHP have highly human immune systems in contrast to other animal species, which makes them very ...
Manufactured by:Atriva Therapeutics GmbH based inTübingen, GERMANY
The company’s lead drug candidate is the MEK inhibitor zapnometinib. The small molecule, which can be administered orally (tablet), is under advanced clinical development in two severe respiratory viral diseases: COVID-19 and influenza, two disease areas with urgent need for effective ...
Manufactured by:MODAG GmbH based inWendelsheim, GERMANY
Certain proteins including α-synuclein can form disease-specific fibrillar amyloid aggregates. The misfolding/ aggregation pathway resulting in amyloid fibrils involves characteristic oligomer species which have been shown to be the most relevant toxic protein species. These pathological oligomers exhibit structural epitopes that are not found in physiologically folded proteins or ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Graft Versus Host Disease (GvHD) is a potentially lethal complication of hematopoietic cell transplantation (HCT) from a donor. When a patient receives a donor’s stem cells, the transplanted cells may identify the patient’s body as foreign and attack it. The chronic form of GvHD occurs at least 100 days following the transplantation. The GvHD market is predicted to exceed $500 million ...
by:Indivumed GmbH based inHamburg, GERMANY
Once a target is identified the various effects of the drug can be measured. This involves all read-outs we use during the biomarker validation but instead of looking at the effect of various candidates we focus on one component. As the tumor microenvironment can play an important role we focus especially on test methods involving fresh tissue. ...
by:PharmaLex GMBH based inFriedrichsdorf, GERMANY
The Global Statistics and Data Science (GSDS) team at PharmaLex delivers analytical support for the development of medical products–from early research through pre-clinical to late phase studies, plus manufacturing and health economics. We support our clients every step of the way–from discovery and non-clinical requirements to early strategic planning, clinical development, CMC ...
by:SGS M-SCAN Ltd based inWokingham, UNITED KINGDOM
With over 25 years of experience and operating out of three GLP compliant laboratories, SGS’s Life Science Services provides pharmacokinetic analysis and bioanalytical services with a dedicated team of specialists. Pharma and biotech companies of all sizes have chosen us as the preferred bioanalytical partner. SGS has the expertise to both develop assays de novo (including immunoassays) and ...